Published February 2, 2021 | Version v1
Patent Open

Treatment of demyelinating disorders

  • 1. University of Chicago

Contributors

Patent applicant:

Description

This invention discloses methods and compositions for the treatment of demyelinating disorders. Specifically, the invention relates to the use guanabenz or guanabenz derivative for treating demyelinating disorders.

Files

US10905663.pdf

Files (2.0 MB)

Name Size Download all
md5:7441ee52c866cd49252b39ae1d694d52
2.0 MB Preview Download

Additional details

Identifiers

Patent number
US 10905663 B2
Patent application number
US 201414773088 A
Other
oai:uchicago.tind.io:7428

Dates

Patent filed
2014-03-05

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Medicine